David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 17,104 shares at $33.76 ($577K) on 2013-04-30, disclosed to the SEC on 2013-05-02.
Scheduled sale ($577k) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.76 | 17,004 | $574K | 99.4% |
| 2 | $34.35 | 100 | $3K | 0.6% |
| Total | $33.76 avg | 17,104 | $577K | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |
| THRX | SELL | 2012-08-07 | $3.5M | — | Filing → |